Contribution of T lymphocytes to the development of bleomycin-induced pulmonary fibrosis.
Department of Microbiology and Immunology, University of Kentucky College of Medicine, Lexington 40536-0084, USA.
J
J
Zhu
D A
DA
Cohen
S N
SN
Goud
A M
AM
Kaplan
D000818:Animals; D001761:Bleomycin / Q000494:pharmacology*; D016572:Cyclosporine / Q000494:pharmacology; D005260:Female; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000378:metabolism; D006909:Hydroxyproline / Q000032:analysis; D007371:Interferon-gamma / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D008168:Lung / Q000737:chemistry; D051379:Mice; D008810:Mice, Inbred C57BL; D016513:Mice, SCID; D010641:Phenotype; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000473:pathology*; D013601:T-Lymphocytes / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D014409:Tumor Necrosis Factor-alpha; D001761:Bleomycin; D018664:Interleukin-12; D007371:Interferon-gamma; D016572:Cyclosporine; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D006909:Hydroxyproline